Tabayag, Violeta S.
HRN: 03-76-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFTRIAXONE 1G (VIAL)
01/21/2025
01/27/2025
IV
2g
IV
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes